FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
RELATED ARTICLES
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US -
Kindstar Globalgene finds bargain in solid tumor testing acquisition
9960.HK
- Bayzed joins IPO quest as medical rivalry heats up
-
New Horizon Health launches probe into disputed sales figures
6606.HK
-
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
GRCL.US
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
